NC0088811_Renewal (Application)_20191203

ied;:a
ROY COOPER r t_4,
GOvcr nor
MICHAEL S.REGANV. w..,,.
Secretary .
LINDA CULPEPPER NORTH CAROLINA
Director Environmental Quality
December 03, 2019
Pharmaceutical Produce Development, LLC.
Attn: Mark Armstrong, Facility Supervisor
929 N Front St
Wilmington, NC 28401
Subject: Permit Renewal
Application No. NC0088811
PPD Groundwater Remediation Site
New Hanover County
Dear Applicant:
The Water Quality Permitting Section acknowledges the November 26, 2019 receipt of your permit renewal application
and supporting documentation. Your application will be assigned to a permit writer within the Section's NPDES WW
permitting branch. Per G.S. 150E-3 your current permit does not expire until permit decision on the application is made.
Continuation of the current permit is contingent on timely and sufficient application for renewal of the current permit. The
permit writer will contact you if additional information is required to complete your permit renewal. Please respond in a
timely manner to requests for additional information necessary to allow a complete review of the application and renewal
of the permit.
Information regarding the status of your renewal application can be found online using the Department of Environmental
Quality's Environmental Application Tracker at:
https://deq.nc.gov/permits-regulations/permit-guidance/environmental-application-tracker
If you have any additional questions about the permit, please contact the primary reviewer of the application using the
links available within the Application Tracker.
Sincerely
XitlIAL)t9,,Atlia
Wren Thedford
Administrative Assistant
Water Quality Permitting Section
ec: WQPS Laserfiche File w/application
Nortfi Caro ra Departs=rt f Ervuonmersta+Quahty I Divisor of Water Re=_. .r s
.DE 3
W m;ngton Reg•Dra Off oc 1127 Cardenas Drve Extensors I Wilm,ngton,North :sro ra 2S4DE
'7 ,\/...'- 910-7M-7215

EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
Form U.S.Environmental Protection Agency
1 \-.EPA Application for NPDES Permit to Discharge Wastewater
NPDES GENERAL INFORMATION
SECTION 1.ACTIVITIES REQUIRING AN NPDES PERMIT(40 CFR 122.21(f)and(f)(1))
1.1 Applicants Not Required to Submit Form 1
1.1.1 Is the facility a new or existing publicly owned 1 1 2 Is the facility a new or existing treatment works
treatment works? treating domestic sewage?
If yes, STOP. Do NOT complete El No If yes,STOP. Do NOT ✓� No
Form 1.Complete Form 2A. complete Form 1.Complete
Form 2S.
1.2 Applicants Required to Submit Form 1
1.2.1 Is the facility a concentrated animal feeding 1.2.2 Is the facility an existing manufacturing.
operation or a concentrated aquatic animal commercial, mining,or silvicultural facility that is
o- production facility? currently discharging process wastewater?
o ❑ Yes 4 Complete Form 1 ❑✓ No ✓� Yes 4 Complete Form No
a. and Form 2B. 1 and Form 2C.
0 1.2.3 Is the facility a new manufacturing,commercial, 1.2.4 Is the facility a new or existing manufacturing,
mining,or silvicultural facility that has not yet commercial,mining,or silvicultural facility that
commenced to discharge? discharges only nonprocess wastewater?
❑ Yes 4 Complete Form 1 ✓❑ No ❑ Yes 4 Complete Form �✓ No
cc and Form 2D. 1 and Form 2E
1.2.5 Is the facility a new or existing facility whose
discharge is composed entirely of stormwater
associated with industrial activity or whose
discharge is composed of both stormwater and RECEIVED
non-stormwater?
Yes 4 Complete Form 1 ❑✓ No NOV 2 6 2019
and Form 2F
unless exempted by NCDEQ/DWR/NPDES
40 CFR
122.26(b)(14)(x)or
b 15 .
SECTION 2.NAME,MAILING ADDRESS,AND LOCATION(40 CFR 122.21(f)(2))
2.1 Facility Name
Pharmaceutical Product Development,LLC. Ground Water Remediation Plant
0 2.2 EPA Identification Number
0 110043162485
-a
co 2.3 Facility Contact
Name(first and last) Title Phone number
Mark Armstrong Supervisor Facilities and Real Estate [phone]
Email address
[e-mail]
2.4 Facility Mailing Address
Street or P.O.box
929 North Front Street
City or town State ZIP code
Wilmington North Carolina 28401
EPA Form 3510-1(revised 3-19) Page 1

EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
u 0 2.5 Facility Location
Street,route number,or other specific identifier
a o 929 North Front Street
rnV
a o County name County code(if known)
a ri New Hanover not known
E City or town State ZIP code
z Wilmington North Carolina 28401
SECTION 3.SIC AND NAICS CODES(40 CFR 122.21(f)(3))
3.1 SIC Code(s) Description(optional)
87319902 Medical research,commercial
� m
0
11 N
3.2 NAICS Code(s) Description(optional)
`6 541715 Research and Development in the Physical,Engineering,and Life Sciences(except
V
SECTION 4.OPERATOR INFORMATION(40 CFR 122.21(f)(4))
4.1 Name of Operator
Pharmaceutical Product Development,Inc.
0 4.2 Is the name you listed in Item 4.1 also the owner?
❑✓ Yes ❑ No
= 4.3 Operator Status
❑ Public—federal ❑ Public—state ❑ Other public(specify)
O ❑✓ Private ❑ Other(specify)
4.4 Phone Number of Operator
[phone]
= 4.5 Operator Address
Street or P.O. Box
E 929 North Front Street
o 2
.E City or town State ZIP code
w o Wilmington North Carolina 28401
co
Q Email address of operator
0 [e-mail]
SECTION 5.IND AN LAND(40 CFR 122.21(f)(5))
c -0 5.1 Is the facility located on Indian Land?
la c
J ❑Yes ❑✓ No
EPA Form 3510-1(revised 3-19) Page 2

EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
SECTION 6.EXISTING ENVIRONMENTAL PERMITS(40 CFR 122.21(f)(6))
6 1 Existing Environmental Permits(check all that apply and print or type the corresponding permit number for each)
Tc
d m NPDES(discharges to surface ❑ RCRA(hazardous wastes) ❑ UIC(underground injection of
oy water) fluids)
2 NC0088811
w a ❑ PSD(air emissions) ❑ Nonattainment program(CM) ❑ NESHAPs(CM)
0 Ocean dumping(MPRSA) 0 Dredge or fill(CWA Section 404) ❑ Other(specify)
SECTION 7.MAP(40 CFR 122.21(f)(7))
7.1 Have you attached a topographic map containing all required information to this application?(See instructions for
specific requirements.)
2
✓❑Yes 0 No ❑ CAFO—Not Applicable(See requirements in Form 2B.)
SECTION 8.NATURE OF BUSINESS(40 CFR 122.21(f)(8))
8.1 Describe the nature of your business.
Pharmaceutical Product Development,LLC is a global contract research organization providing comprehensive,
U) integrated drug development,laboratory and lifecycle management services.
U)
U)
"6
G)
Co
z
SECTION 9.COOLING WATER INTAKE STRUCTURES(40 CFR 122.21(f)(9))
9.1 Does your facility use cooling water?
❑ Yes ❑� No 4 SKIP to Item 10.1.
9.2 Identify the source of cooling water.(Note that facilities that use a cooling water intake structure as described at
40 CFR 125,Subparts I and J may have additional application requirements at 40 CFR 122.21(r).Consult with your
o Y NPDES permitting authority to determine what specific information needs to be submitted and when.)
o ,�
C
SECTION 10.VARIANCE REQUESTS(40 CFR 122.21(f)(10))
10.1 Do you intend to request or renew one or more of the variances authorized at 40 CFR 122.21(m)?(Check all that
apply. Consult with your NPDES permitting authority to determine what information needs to be submitted and
5 when.)
Cr ❑ Fundamentally different factors(CWA ❑ Water quality related effluent limitations(CWA Section
e Section 301(n)) 302(b)(2))
❑ Non-conventional pollutants(CWA 0 Thermal discharges(CWA Section 316(a))
Section 301(c)and(g))
❑✓ Not applicable
EPA Form 3510-1(revised 3-19) Page 3

EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
SECTION 11.CHECKLIST AND CERTIFICATION STATEMENT(40 CFR 122.22(a)and(d))
11.1 In Column 1 below, mark the sections of Form 1 that you have completed and are submitting with your application.
For each section,specify in Column 2 any attachments that you are enclosing to alert the permitting authority.Note
that not all applicants are required to provide attachments.
Column 1 Column 2
✓❑ Section 1:Activities Requiring an NPDES Permit ❑ w/attachments
✓❑ Section 2: Name, Mailing Address,and Location ❑ w/attachments
✓❑ Section 3:SIC Codes ❑ w/attachments
✓❑ Section 4:Operator Information ❑ w/attachments
O Section 5: Indian Land ❑ w/attachments
0 Section 6: Existing Environmental Permits ❑ wl attachments
0Section 7: Map WI topographic ❑ wl additional attachments
c 0 Section 8:Nature of Business ❑ wl attachments
❑✓ Section 9:Cooling Water Intake Structures 0 w/attachments
-o
0Section 10:Variance Requests 0 w/attachments
✓❑ Section 11:Checklist and Certification Statement 0 wl attachments
11.2 Certification Statement
U
I certify under penalty of law that this document and all attachments were prepared under my direction or supervision
in accordance with a system designed to assure that qualified personnel properly gather and evaluate the
information submitted. Based on my inquiry of the person or persons who manage the system, or those persons
directly responsible for gathering the information,the information submitted is,to the best of my knowledge and
belief, true,accurate,and complete. I am aware that there are significant penalties for submitting false information,
including the possibility of fine and imprisonment for knowing violations.
Name(print or type first and last name) Official title
Mark Armstrong Supervisor Facilities and Real Estate
Signature� �/ Date signed
/'�L%Ct/1.fPi.�`/,2mtdti.47- 11/20/2019
EPA Form 3510-1(revised 3-19) Page 4

• ', M
- -- -,- „"•:,4,--,,,N0...„, ttik. itilt0 • f ..,:•'„#„:„..i•„,„ • • -„ v=., . . ,-. •,. •,•:0,„;•0:•„0:- , „0.„... 0:4 1•:•,•„„2.„.,-„Attio,„#4.411-
i •-. •,$: . ..*r-- #1-:" .4. -,,•—'24it,,i"„,--.0;: . ..,„„, .
" Kiilkit*-4,:!4„,..„1„-
- 2• "
,a A tom.:00---..,,,,7;iii : • _ „.„„,":„..„,„",„„„„,..." r"f 4 ? a ;g# . • b *
x`
ta . .* . •.may:$g jrajiL
/ a Ar... it•
r
t -4
4! ,,S0'••'•'•••,•,,,,,7 \i -.4.,. •r ,:--,. •• , - . . "•..,," * '•"-,;*,,,,••", ---,141,-,,„,„::-,-- '.!"-
b
mot
'. • ,I.„ poitt&togloadiri rA,..,.7-?,,,:t...,,,.
(tit,„ I A „,,....R ...' :,,'';„1,14-,11.,;:..--;A -!,,: !,1::: t„-•:-„,,,..I 4..-,.',.,--v---;:.-,;:';
'' r--''''/ '.' .74ie'-74 i-
~ 08 $ .
tt;''. ----- i• • . • Facility s 5 ' gip:
s
--6--il'
. i ill" . 6 i. ... „...... .. - - -* ''- ' I.:
,.1%, iiiii
i • a••►♦ '�s jj�
((��((��Q'�tt ��}}'1 z f-lik,i,.•.,„-,.....-.. 1,..,,,,,,,,,::,,,,,,r,, *
i -. NCVLVW .I.A -- 1 - - � f -
•
' -:•!0.,•'.--. ' N., 4-1001:„:--•.."•...! „',......-•„:"II- 74 iiii,...o. 14 :-.,""--,--,e.„.-4,e:.....44„,.r ,-... * "'k, -, ,,.. -- ....".".`':Pik,-..,"
16 .".ti : '•---..-.....„„11 , . ...,. •. 'AO::.;.:•-...........4*;e"*"'' "'*--1,---:**"Z----: 4. -'''':11•-•••':''''' . ". ''''" : •,,''' :•:'- .. --- '
*%\,*. • • ". ,'",""gr:****„."':".11- -r -- ...itAit , '107'7. -,,,'jai 7;6 „...... tliptiorp_ ...------_.-.----_:_.,:::-!::::::--'.- *..--4-,. .-------::--
\ ,.. •Z ) .:.::.,:•••i••:,:-4,,,,..i„!-.:.,•,,..,,*.t•.t.,. ,.........,::::_.,-.--re,•:..-.,,,•:. •:--4:--..---.-.•.....0,„:„.:„....,:.14,.....;...$41,3:i.:,..,,•:,...,:.:ii.,....:,,„...0..,,,,ita:. ,.• „,,,,,.,.:,,,,., t4..., .....,,,,...„1„,„:::„... r...,„ ... ,, ,
_, ',----- :•.,,„„-;--,-:.--..r.71,,,-,-,:•, ,...4,-.4..1.1,fi.:., .. -v. ..., . ., .'Cr_12,..,..,„,.,..,,'„. Discharge •••• • .. : .----;=4,...is. ..,.,....,•:. re.;.,e, ., ,
0. SS, 4• *1 ••-
ni.
'-ii:lite.i':--i'i.-.m...r•'''',
,,, .i.s. , .tea
• (} .
sTIN. • • • ! • ..•-t Arm
�, sa •
I
„f..,... - . ..,.....,-,•,„.„,,„„lk--•.--•: • ' - --- ,' .- \'' '''-;•• i''''''1..;...-.1::.--,-',-,.-•:--!:,,'"...*'1"..w.•010....,::........,.-7..„.".- Ilk•.'•'•','0,.:. .'‘i''..-',..-•-'-',:cill,:;..-''''''...1.''''"i;•''''1,-;:1;-'.-....'''''-'115-1-';' -'-'-'"---''''-'-'",--*--:-:-•-••'••."' •,'"*-1:-1-ts'-'1'.4r-'.--,77.-:"'"'J'-'''''. '-"*--'•-:-'::::
-,• ---- , -•••-,--,"•- ' ' ' : -4\ tit,',, -.. , •-•W•• --..-.,00i -... :,„r, -• • . .0'401.,-• .. . ,-: • ..-::
:: 4.'",-• ----ii--.-:-ii ki- -(1,ARix.rts:-...‘\ • - s, i..- : -..-,i.::',•irilei'• .,---. ---H --,ifit:Iii. .t.,,-.. ...:------!,- -...,:f7.7.7.-7 ,-i---:- -,-.. ' , • •:.-7
•.1 - .-.-$:,:‘:‘,,V1':'::''''''.;- -• :,:„-ti I ti ..! „ : : - : tH-.±,•::'•„,.:. 0::--,',.. ..,.--r--i. -.4' •--di - - rook; 1 ,••-•)--i•kl:•: •: :,:
USGS Quad: K27NW Wilmington, NC
Outfall Facility Facility
Latitude: 34° 14' 35" N 34° 14'45.2" N
Location •
Longitude: 77°57'4"W 77° 56'56.3"W � ` �.
Stream Class: SC, Sw
1
Subbasin: 03-06-23 Pharmaceutical Product Development, Inc.
Receiving Stream: Northeast Cape Fear River North NC0088811 -New Hanover County

•
EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
Form U.S.Environmental Protection Agency
2C Cif EPA Application for NPDES Permit to Discharge Wastewater
NPDES EXISTING MANUFACTURING,COMMERCIAL,MINING,AND SILVICULTURE OPERATIONS
SECTIO 1.OUTFALL LOCATION(40 CFR 122.21(g)(1))
1.1 Provide information on each of the facility's outfalls in the table below.
o Numbelr Receiving Water Name Latitude Longitude
001 Northeast Cape Fear 34° 14' 35" N 77' 57' 4" W
0
SECTION 2.LINE DRAWING(40 CFR 122.21(g)(2))
p, 2.1 Have you attached a line drawing to this application that shows the water flow through your facility with a water
.3 balance?(See instructions for drawing requirements. See Exhibit 2C-1 at end of instructions for example.)
J R
o ❑✓ Yes ❑ No
SECTION 3.AVERAGE FLOWS AND TREATMENT(40 CFR 122.21(g)(3))
3.1 For each outfall identified under Item 1.1,provide average flow and treatment information.Add additional sheets if
necessary.
**Outfall Number** 001
Operations Contributing to Flow
Operation Average Flow
GROUNDWATER .029 mgd
E'
mgd
is
mgd
mgd
Treatment Units
a, Description Code from Final Disposal of Solid or
(include size,flow rate through each treatment unit, Table 2C-1 Liquid Wastes Other Than
. retention time,etc.) by Discharge
NA NA NA
RECEIVED
NOV 2 6 2019
NCOEQIDWR/NPDES
EPA Form 3510-2C(Revised 3-19) Page 1

EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
3.1 **Outfall Number**
cont. Operations Contributing to Flow
Operation Average Flow
NA NA mgd
mgd
mgd
mgd
Description Final Disposal of Solid or
(include size,flow rate through each treatment unit, Code from Liquid Wastes Other Than
retention time,etc.) Table 2C 1 by Discharge
v NA NA NA
c
•C
O
V
C
4)
E
N
H
**Outfall Number**
Operations Contributing to Flow
o Operation Average Flow
rn NA NA mgd
m
m
a' mgd
mgd
mgd
Treatment Units
Description Code from Final Disposal of Solid or
(include size,flow rate through each treatment unit, Table 2C-1 Liquid Wastes Other Than
retention time,etc.) by Discharge
NA NA NA
3.2 Are you applying for an NPDES permit to operate a privately owned treatment works?
E ❑✓ Yes El No+ SKIP to Section 4.
th
M 3.3 Have you attached a list that identifies each user of the treatment works?
❑ Yes ❑✓ No
EPA Form 3510-2C(Revised 3-19) Page 2

EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
SECTION 4.INTERMITTENT FLOWS(40 CFR 122.21(g)(4))
4.1 Except for storm runoff,leaks,or spills,are any discharges described in Sections 1 and 3 intermittent or seasonal?
❑ Yes ✓❑ No 4 SKIP to Section 5.
4.2 Provide information on intermittent or seasonal flows for each applicable outfall.Attach additional pages.if necessary.
Outfall Operation Fre uency Flow Rate
Number (list) Average Average Long-Term Maximum Duration
Days/Week Months/Year Average Daily
days/week months/year mgd mgd days
o days/week months/year mgd mgd days
a
days/week months/year mgd mgd days
days/week months/year mgd mgd days
days/week months/year mgd mgd days
days/week months/year mgd mgd days
days/week months/year mgd mgd days
days/week months/year mgd mgd days
days/week months/year mgd mgd days
SECTION 5.PRODUCTION(40 CFR 122.21(g)(5))
5.1 Do any effluent limitation guidelines(ELGs)promulgated by EPA under Section 304 of the CWA apply to your facility?
❑ Yes ❑✓ No 4 SKIP to Section 6.
5.2 Provide the following information on applicable ELGs.
w ELG Category ELG Subcategory Regulatory Citation
Q
Q
5.3 Are any of the applicable ELGs expressed in terms of production(or other measure of operation)?
❑ Yes ❑ No 4 SKIP to Section 6.
0
5.4 Provide an actual measure of daily production expressed in terms and units of applicable ELGs.
2.1 Outfall Operation,Product,or Material Quantity per Day Unit of
Number Measure
Co
CO
0
0
0
0
a`
EPA Form 3510-2C(Revised 3-19) Page 3

EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
SECTION 6. IMPROVEMENTS(40 CFR 122.21(g)(6))
6.1 Are you presently required by any federal,state,or local authority to meet an implementation schedule for constructing,
upgrading,or operating wastewater treatment equipment or practices or any other environmental programs that could
affect the discharges described in this application?
❑ Yes ❑✓ No 4 SKIP to Item 6.3.
6.2 Briefly identify each applicable project in the table below.
Affected Final Compliance Dates
Brief Identification and Description of Outfalls Source(s)of
Project (list outfall Discharge Required Projected
El"
number)
E
R '
N
a)
13
a)
Q
6.3 Have you attached sheets describing any additional water pollution control programs(or other environmental projects
that may affect your discharges)that you now have underway or planned?(optional item)
❑ Yes ❑ No ✓❑ Not applicable
SECTION 7.EFFLUENT AND INTAKE CHARACTERISTICS(40 CFR 122.21(g)(7))
See the instructions to determine the pollutants and parameters you are required to monitor and, in turn,the tables you must
complete.Not all applicants need to complete each table.
Table A.Conventional and Non-Conventional Pollutants
7.1 Are you requesting a waiver from your NPDES permitting authority for one or more of the Table A pollutants for any of
your outfalls?
❑ Yes ❑✓ No 4 SKIP to Item 7.3.
7.2 If yes, indicate the applicable outfalls below.Attach waiver request and other required information to the application.
Outfall Number Outfall Number Outfall Number
7.3 Have you completed monitoring for all Table A pollutants at each of your outfalls for which a waiver has not been
requested and attached the results to this application package?
42)
El Yes ❑ No;a waiver has been requested from my NPDES
permitting authority for all pollutants at all outfalls.
as
i; Table B.Toxic Metals,Cyanide,Total Phenols,and Organic Toxic Pollutants
7.4 Do any of the facility's processes that contribute wastewater fall into one or more of the primary industry categories
cts
listed in Exhibit 2C-3?(See end of instructions for exhibit.)
❑ Yes ✓❑ No 4 SKIP to Item 7.8.
4,3
7.5 Have you checked"Testing Required"for all toxic metals,cyanide,and total phenols in Section 1 of Table B?
ra ❑ Yes ❑ No
7.6 List the applicable primary industry categories and check the boxes indicating the required GC/MS fraction(s)identified
in Exhibit 2C-3.
Primary Industry Category Required GC/MS Fraction(s)
(Check applicable boxes.)
❑Volatile 0 Acid 0 Base/Neutral 0 Pesticide
0 Volatile 0 Acid 0 Base/Neutral 0 Pesticide
❑Volatile ❑Acid 0 Base/Neutral 0 Pesticide
EPA Form 3510-2C(Revised 3-19) Page 4

EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
7.7 Have you checked"Testing Required"for all required pollutants in Sections 2 through 5 of Table B for each of the
GC/MS fractions checked in Item 7.6?
O Yes ❑ No
7.8 Have you checked`Believed Present"or"Believed Absent"for all pollutants listed in Sections 1 through 5 of Table B
where testing is not required?
❑✓ Yes ❑ No
7.9 Have you provided(1)quantitative data for those Section 1,Table B,pollutants for which you have indicated testing is
required or(2)quantitative data or other required information for those Section 1,Table B,pollutants that you have
indicated are"Believed Present"in your discharge?
✓❑ Yes ❑ No
7.10 Does the applicant qualify for a small business exemption under the criteria specified in the instructions?
❑ Yes 4 Note that you qualify at the top of Table B, ❑✓ No
then SKIP to Item 7.12.
= 7.11 Have you provided(1)quantitative data for those Sections 2 through 5,Table B,pollutants for which you have
o determined testing is required or(2)quantitative data or an explanation for those Sections 2 through 5,Table B,
m pollutants you have indicated are"Believed Present"in your discharge?
`—' D Yes ❑ No
Table C.Certain Conventional and Non-Conventional Pollutants
R 7.12 Have you indicated whether pollutants are"Believed Present"or"Believed Absent"for all pollutants listed on Table C
for all outfalls?
✓❑ Yes ❑ No
7.13 Have you completed Table C by providing(1)quantitative data for those pollutants that are limited either directly or
c indirectly in an ELG and/or(2)quantitative data or an explanation for those pollutants for which you have indicated
`Believed Present"?
p Yes ❑ No
w Table D.Certain Hazardous Substances and Asbestos
7.14 Have you indicated whether pollutants are"Believed Present"or"Believed Absent"for all pollutants listed in Table D for
all outfalls?
✓❑ Yes 0 No
7.15 Have you completed Table D by(1)describing the reasons the applicable pollutants are expected to be discharged
and(2)by providing quantitative data,if available?
❑✓ Yes ❑ No
Table E.2,3,7,8-Tetrachlorodibenzo-p-Dioxin(2,3,7,8-TCDD)
7.16 Does the facility use or manufacture one or more of the 2,3,7,8-TCDD congeners listed in the instructions,or do you
know or have reason to believe that TCDD is or may be present in the effluent?
O Yes 4 Complete Table E. ElNo 4 SKIP to Section 8.
7.17 Have you completed Table E by reporting qualitative data for TCDD?
❑ Yes ❑ No
SECTION 8.USED OR MANUFACTURED TOXICS(40 CFR 122.21(g)(9))
8.1 Is any pollutant listed in Table B a substance or a component of a substance used or manufactured at your facility as
an intermediate or final product or byproduct?
`_ ❑ Yes ❑✓ No-> SKIP to Section 9.
8.2 List the pollutants below.
1. 4. 7.
2. 5. 8.
� I
3. 6. 9.
EPA Form 3510-2C(Revised 3-19) Page 5

EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
SECTION 9.BIOLOGICAL TOXICITY TESTS(40 CFR 122.21(g)(11))
9.1 Do you have any knowledge or reason to believe that any biological test for acute or chronic toxicity has been made
within the last three years on(1)any of your discharges or(2)on a receiving water in relation to your discharge?
❑ Yes ❑✓ No 4 SKIP to Section 10.
9.2 Identify the tests and their purposes below.
Test(s) Purpose of Test(s) Submitted to NPDES Date Submitted
xPermitting Authority?
o ❑ Yes ❑ No
o
❑ Yes ❑ No
❑ Yes ❑ No
SECTION 10.CONTRACT ANALYSES(40 CFR 122.21(g)(12))
10.1 Were any of the analyses reported in Section 7 performed by a contract laboratory or consulting firm?
❑✓ Yes ❑ No 4 SKIP to Section 11.
10.2 Provide information for each contract laboratory or consulting firm below.
Laboratory Number 1 Laboratory Number 2 Laboratory Number 3
Name of laboratory/firm Pace Analytical,LLC
U)
Laboratory address 9800 Kincey Ave,suite 100,
To
Huntersville,NC 28078
co
to
0 Phone number
U
[phone]
Pollutant(s)analyzed
SECTION 11.ADDITIONAL INFORMATION(40 CFR 122.21(g)(13))
11.1 Has the NPDES permitting authority requested additional information?
❑ Yes ✓❑ No 4 SKIP to Section 12.
0
a, 11.2 List the information requested and attach it to this application.
'6
1. 4.
711
-cs 2. 5.
Q _
3. 6.
EPA Form 3510-2C(Revised 3-19) Page 6

EPA Identification Number NPDES Permit Number Facility Name Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product OMB No.2040-0004
SECTION 12.CHECKLIST AND CERTIFICATION STATEMENT(40 CFR 122.22(a)and(d))
12.1 In Column 1 below, mark the sections of Form 2C that you have completed and are submitting with your application.
For each section,specify in Column 2 any attachments that you are enclosing to alert the permitting authority.Note
that not all applicants are required to complete all sections or provide attachments.
Column 1 Column 2
✓❑ Section 1:Outfall Location ✓❑ wl attachments
✓❑ Section 2:Line Drawing ✓❑ w/line drawing ❑ w/additional attachments
Section 3:Average Flows and w/list of each user of
Treatment El w/attachments privately owned treatment
works
✓❑ Section 4:Intermittent Flows ❑ wl attachments
❑✓ Section 5: Production ❑ w/attachments
w/optional additional
❑✓ Section 6: Improvements ❑ w/attachments ❑ sheets describing any
additional pollution control
plans
❑ w/request for a waiver and ❑ w/explanation for identical
supporting information outfalls
wl small business exemption w/other attachments
❑ request El
✓❑ Section 7:Effluent and Intake ✓❑ wl Table A ❑ w/Table B
Characteristics
0
✓❑ w/Table C ❑ w/Table D
d ✓ w/Table E w/analytical results as an
c� ❑ ❑ attachment
✓❑ Section 8:Used or Manufactured ❑ w/attachments
174 Toxics
❑ Section 9: Biological Toxicity ❑ w/attachments
-c Tests
U
✓❑ Section 10:Contract Analyses ❑ w/attachments
✓❑ Section 11:Additional Information D w/attachments
❑ Section 12:Checklist and El w/attachments
Certification Statement
12.2 Certification Statement
I certify under penalty of law that this document and all attachments were prepared under my direction or supervision in
accordance with a system designed to assure that qualified personnel properly gather and evaluate the information
submitted. Based on my inquiry of the person or persons who manage the system,or those persons directly
responsible for gathering the information,the information submitted is, to the best of my knowledge and belief,true,
accurate,and complete.I am aware that there are significant penalties for submitting false information,including the
possibility of fine and imprisonment for knowing violations.
Name(print or type first and last name) Official title
Mark Armstrong Supervisor Facilities and Real Estate
Signature Date signed
11/20/2019
EPA Form 3510-2C(Revised 3-19) Page 7

This page intentionally left blank.

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19 .
110043162485 NC0088811 Pharmaceutical Product 001 OMB No.2040-0004 1
TABLE A.CONVENTIONAL AND NON CONVENTIONAL POLLUTANTS(40 CFR 122.21(g)(7)(iii))1
Effluent Intake
Waiver (Optional)
Pollutant Reguested Units Maximum Maximum Long-Term
Of applicable
) (specify) Daily Monthly Average Daily Number of Long-Term Number of
Discharge Discharge Discharge Analyses Average Value Analyses
(required) (if available) (if available)
❑ Check here if you have applied to your NPDES permitting authority for a waiver for all of the pollutants listed on this table for the noted outfall.
Biochemical oxygen demand Concentration mg/L 74.2 74.2 10
1' El(BODs) Mass
Chemical oxygen demand Concentration mg/L 57 57 10
2' El(COD) Mass
Concentration - - - -
3. Total organic carbon(TOC) ❑
Mass
Concentration - - - -
4. Total suspended solids(TSS) ❑
Mass
Concentration mg/L 69.3 69.3 10
5. Ammonia(as N) ❑
Mass
6. Flow ❑ Rate gallons 18408 499550 13495 18825
Temperature(winter) ❑ °C °C 13.1 13.1
7.
Temperature(summer) ❑ °C °C 26.7 26.7
pH(minimum) ❑ Standard units s.u. 7.08 7.08
8.
pH(maximum) ❑ Standard units s.u. 8.67 8.67
1 Sampling shall be conducted according to sufficiently sensitive test procedures(i.e.,methods)approved under 40 CFR 136 for the analysis of pollutants or pollutant parameters or
required under 40 CFR chapter I,subchapter N or 0.See instructions and 40 CFR 122.21(e)(3).
EPA Form 3510-2C(Revised 3-19) Page 9

This page intentionally left blank.

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0O88811 Pharmaceutical Product 001 OMB No.2040-0004
4illie eidt41,t113ORIZINaklE111011Z[]IV_IIII•1:Z01ZUsitiMiI 1»4j>f_141--X Ali 4AN*4
Presence or Absence Intake
(check one) Effluent (optional)
Pollutant/Parameter Testing Units Long-Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long Number
of
Analyses
Present Absent Daily Monthly Daily of Term
Discharge Discharge Discharge Analyses Average
(required) (if available) Value
(if available)
❑
Check here if you qualify as a small business per the instructions to Form 2C and,therefore,do not need to submit quantitative data for any of the organic toxic pollutants in Sections
2 through 5 of this table.Note,however,that you must still indicate in the appropriate column of this table if you believe any of the pollutants listed are present in your discharge.
Section 1.Toxic Metals,Cyanide,and Total Phenols
Antimony,total Concentration
1.1 0 El
(7440-36-0) Mass
Arsenic,total Concentration mg/L .0422 .0422 59
1.2 0 El
(7440-38-2) Mass
1.3 Beryllium,total El Concentration
(7440-41-7) Mass
1.4 Cadmium,total 0 Concentration
El El
(7440-43-9) Mass
1.5 Chromium,total 0 Concentration mg/L .0733 .0733 59
0 El
(7440-47-3) Mass
1.6 Copper,total 0 Concentration mg/L .0597 .0597 59
El El
(7440-50-8) Mass
1.7 Lead,total Concentration
0 El El
(7439-92-1) Mass
1.8 Mercury,total � ❑ Concentration
(7439-97-6) Mass
Nickel,total Concentration mg/L .021 .021 10
1'9 El El
(7440-02-0) Mass
1.10 Selenium,total El El 0 Concentration
(7782-49-2) Mass
Silver,total Concentration
1.11 0 0
(7440 22 4)
Mass
EPA Form 3510-2C(Revised 3-19) Page 11

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product 001 OMB No.2040-0004
11:let•?3[•lr'd4LW:K•f I`Ilil*t•WllCaa4Z[CisILVlibli{cLIZI[ •?:DLr•]Ill.ljf_kt:nwmzgil' l
Presence or Absence Intake
(check one) Effluent (optional)
Pollutant/Parameter Testing Units Long-Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long Number
Present Absent Daily Monthly Daily of Term of
D(req i edge Dischar(if ava labllee) De ischarge Analyses Term
Analyses
(if available) _
1.12 Thallium,total � Concentration
(7440-28-0) ✓ Mass
1.13 Zinc,total El ❑ Concentration mg/L 0.16 0.16 59
(7440-66-6) Mass
1.14 Cyanide,total 0 Concentration
0 El
(57-12-5) Mass
1.15 Phenols,total Concentration
Mass
Section 2.Organic Toxic Pollutants(GC/MS Fraction—Volatile Compounds)
21 Acrolein 0 Concentration
(107-02-8) Mass
2.2 Acrylonitrile 0 El 0 Concentration
(107-13-1) Mass
2.3 Benzene Concentration
-
0(71-43-2) ✓ Mass
Bromoform Concentration
2.4 (75-25-2) � � L Mass
2.5 Carbon tetrachloride 0 Concentration
(56-23-5) Mass
Chlorobenzene 0 Concentration
2.6 0 CI
(108-90-7) Mass
2.7 Chlorodibromomethane �
Concentration
(124-48-1) ✓ Mass
Chloroethane 0 Concentration
2.8 El 0 •
(75 00 3)
Mass
EPA Form 3510-2C(Revised 3-19) Page 12

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product 001 OMB No.2040-0004
*MOB lya I4LIIMWEI 111111t•1f1RIJ:I.7, WWII:IiteliteLl:I[eta):IId;1•]il Ili;9ZTMI J:11F 11
Presence or Absence Intake
(check one) Effluent (optional)
Pollutant/Parameter Testing Units Long Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long Number
Analyses
Present Absent Daily Monthly Termof
Discharge Discharge DisDcharge Analyses Average
(required) (if available) Value
of
a(if available)
2.9 2-chloroethylvinyl ether El ❑ ❑ Concentration
(110-75-8) Mass
Concentration
2.10 Chloroform(67-66-3) 0 0 ❑✓ Mass
2.11 Dichlorobromomethane ❑ 0 ❑ Concentration
(75-27-4) Mass
212 1,1-dichloroethane ❑ 0 ❑ Concentration
(75-34-3) Mass
2.13 1,2-dichloroethane ❑ ❑ ❑ Concentration
(107-06-2) Mass
2.14 1,1-dichloroethylene El 0
❑ Concentration
(75-35-4) Mass
2.15 12-dichloropropane ❑ ❑ ❑ Concentration
(78-87-5) Mass
2.16 1,3-dichloropropylene ❑ ❑ ❑ Concentration
(542 75 6)
Mass
Ethylbenzene Concentration
2.17 (100-41-4) 0 0 Mass •
2.18 Methyl bromide ❑ 0
Concentration
(74-83-9) ✓ Mass
219 Methyl chloride 0 ❑ ❑ Concentration
(74-87-3) Mass
2.20 Methylene chloride ❑ ❑ ❑ Concentration
(75-09-2) Mass
2.21 1,1,2,2-tetrachloroethane ❑ 0
❑ Concentration
(79-34-5) Mass
EPA Form 3510-2C(Revised 3-19) Page 13

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product 001 OMB No.2040-0004
*NMI IdJil# 14114711ZIIIIMI011/•14:I:ImZ[e7FAI_I211101aeLlZDa MN as]RI1El alf DM4Aitill
Presence or Absence Intake
(check one) Effluent (optional)
Pollutant/Parameter Testing Units Long-Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long Number
Present Absent Daily Monthly Daily of Term of
Discharge Discharge Discharge Analyses Average Analyses
(required) (if available) Value
(if available)
2.22 Tetrachloroethylene � Concentration
El 0
(127-18-4) ✓ Mass
2.23 Toluene Concentration
(108-88-3) ✓ Mass
2.24 1,2-trans-dichloroethylene ❑ 0Concentration
(156-60-5) Mass
2.25 1,1,1-trichloroethane ❑ ❑ Concentration
(71-55-6) Mass
2.26 1,1,2-trichloroethane 0 Concentration
(79-00-5) Mass
2.27 Trichloroethylene 0Concentration
(79-01-6) Mass
2.28 Vinyl chloride � Concentration
El 0
(75-01-4) ✓ Mass
Section 3.Organic Toxic Pollutants(GCIMS Fraction—Acid Compounds)
3.1 2-chlorophenol 0Concentration
El El
(95-57-8) Mass
2,4-dichlorophenol Concentration
3.2 El El
(120-83-2) ✓ Mass _
2,4-dimethylphenol Concentration
3.3 El 0
(105-67-9) Mass
4,6-dinitro-o-cresol Concentration
3.4 0 El
(534-52-1) Mass
3.5 2,4-dinitrophenol 0Concentration
El 0
(51-28-5) Mass
EPA Form 3510-2C(Revised 3-19) Page 14

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product 001 OMB No.2040-0004
Presence or Absence Intake
(check one) Effluent (optional)
PollutantlParameter Testing Units Long-Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long Number
Present Absent Daily Monthly Daily of Term of
Discharge Discharge Discharge Analyses Average Analyses
(required) (if available) Value
(if available)
3.6 2-nitrophenol Concentration
(88-75-5) Mass
4-nitrophenol Concentration
3.7 (100-02-7) Mass
3.8 p-chloro-m-cresol Concentration
(59-50-7) ✓ Mass
Pentachlorophenol 0 Concentration
3.9 0 0
(87-86-5) Mass
Phenol Concentration
3.10 (108-95-2) Mass
3.11 2 4,6-trichlorophenol Concentration
(88-05-2) Mass
Section 4.Organic Toxic Pollutants(GC/MS Fraction—Base/Neutral Compounds)
4.1 Acenaphthene ❑ 0 Concentration
(83-32-9) Mass
Acenaphthylene 0 Concentration
4.2 (208-96-8) Mass
Anthracene Concentration
4.3 El El
(120-12-7) Mass
Benzidine 0 Concentration
4.4 (92-87-5) Mass
Benzo(a)anthracene Concentration
4.5 (56-55-3) Mass
4.6 Benzo(a)pyrene O Concentration
(50-32-8) Mass
EPA Form 3510-2C(Revised 3-19) Page 15

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0O88811 Pharmaceutical Product 001 OMB No.2040-0004
Presence or Absence
(check one) Effluent Intake i
(optional)
PollutantiParameter Testing Units Long Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long Number
Present Absent Daily Monthly Daily of Term of
Discharge Discharge Discharge Analyses Average Analyses
(required) (if available) Value
(if available)
4.7 3,4-benzofluoranthene ❑ 0 ❑ Concentration
(205-99-2) Mass
4.8 Benzo(ghi)perylene ❑ Concentration
El 1=1
(191-24-2) Mass _
4.9 Benzo(k)fluoranthene ❑ Concentration
ID 0
(207-08-9) Mass
Bis(2-chloroethoxy)methane 0 Concentration
4.10 (111-91-1) Mass
Bis(2-chloroethyl)ether 0 Concentration
4.11 (111 44 4) ❑ �
Mass
Bis(2-chloroisopropyl)ether 0 Concentration
4.12 (102-80-1) Mass
4.13 Bis(2-ethylhexyl)phthalate ❑ Concentration
(117-81-7) Mass
4-bromophenyl phenyl ether 0 Concentration
4.14 (101-55-3) Mass
4.15 Butyl benzyl phthalate ❑ ❑ Concentration
(85-68-7) Mass
4.16 2-chloronaphthalene ❑ 0 ❑ Concentration
(91-58-7) Mass
4-chlorophenyl phenyl ether 0 Concentration
4.17 (7005 72 3) ❑ ❑
Mass
Chrysene 0 Concentration
4.18 (218-01-9) Mass
4.19 Dibenzo(a,h)anthracene ❑ ❑ Concentration
(53-70-3) Mass
Page 16
EPA Form 3510-2C(Revised 3-19)

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product 001 OMB No.2040-0004
Presence or Absence Intake
(check one) Effluent (optional)
Pollutant/Parameter Testing Units Long-Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long- Number
Present Absent Daily Monthly Daily of Term of
uDisc iced) ifavalabe) Discharge Analyses AverageValue Analyses
(if available) _
-
4.20 12-dichlorobenzene ❑ El ❑ Concentration
(95-50-1) Mass
1,3-dichlorobenzene Concentration
4.21 (541-73-1) ❑ ❑
Mass
4.22 1,4-dichlorobenzene ❑ Concentration
(106-46-7) Mass
4.23 3,3-dichlorobenzidine El Concentration
(91-94-1) Mass
4.24 Diethyl phthalate El © Concentration
(84-66-2) Mass
4.25 Dimethyl phthalate 0Concentration
(131-11-3) Mass
4.26 Di-n-butyl phthalate ❑ © Concentration
(84-74-2) Mass
2,4-dinitrotoluene Concentration
4.27 (121-14-2) © Mass
4.28 2,6-dinitrotoluene ❑ ❑ Concentration
(606-20-2) Mass
Di-n-octyl phthalate Concentration
4.29 (117-84-0) ❑ ❑ ❑✓ Mass
4.30 1,2-Diphenylhydrazine ❑ ❑ 0Concentration
(as azobenzene)(122-66-7) Mass
Fluoranthene 0 Concentration
4.31 0 0
(206-44-0) Mass
4.32 Fluorene ❑ Concentration
El El
(86-73-7) Mass
Page 17
EPA Form 3510-2C(Revised 3-19)

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product 001 OMB No.2040-0004
TABLE B.TOXIC METALS,CYANIDE,TOTAL PHENOLS,AND ORGANIC TOXIC POLLUTANTS(40 CFR 122.21(g)(7)(v))1
Presence or Absence Intake
(check one) Effluent (optional)
Pollutant/Parameter Testing Units Long-Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long- Number
Present Absent Daily Monthly Daily of Term of
Discharge Discharge Discharge Analyses Average Analyses
(required) (if available) Value
(if available)
4.33 Hexachlorobenzene 0 Concentration
0 El
(118-74-1) Mass
4.34 Hexachlorobutadiene ElConcentration
0 El
(87-68-3) Mass
4.35 Hexachlorocyclopentadiene 0 0 ❑ Concentration
(77-47-4) Mass
4.36 Hexachloroethane 0 Concentration
(67-72-1) Mass
4.37 Indeno(1,2,3-cd)pyrene 0 ❑ Concentration
(193-39-5) Mass
4.38 Isophorone ElConcentration
(78-59-1) Mass
4.39 Naphthalene 0 Concentration
0 0
(91-20-3) Mass
4.40 Nitrobenzene ✓❑ Concentration
0 0
(98-95-3) Mass
4.41 N-nitrosodimethylamine El 0 ❑ Concentration
(62-75-9) Mass
N-nitrosodi-n-propylamine 12 Concentration
4.42 El 0
(621-64-7) Mass
4.43 N-nitrosodiphenylamine El El Concentration
(86-30-6) Mass
4.44 Phenanthrene 0 Concentration
0 0
(85-01-8) Mass
Pyrene Concentration
El 0 El
4.45 (129-00-0) Mass
EPA Form 3510-2C(Revised 3-19) Page 18

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product 001 OMB No.2040-0004
TABL : •. u _ _. I • _ '. k• _. II •: . •. '• UT_k (' I F: 1 (:)(7)(v))1
Presence or Absence Intake
(check one) Effluent (optional)
Pollutant/Parameter Testing Units Long-Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long Term Number
Present Absent
Daily Monthly
Daily
Discharge Discharge Discharge Analyses Average Analyses
(required) (if available) Value
(if available)
1,2,4-trichlorobenzene Concentration
4.46 (120-82-1) Mass
Section 5.Organic Toxic Pollutants(GC/MS Fraction—Pesticides)
Aldrin Concentration
5.1 (309 00 2) ❑ ❑ 0 Mass
a-BHC Concentration
5.2 (319-84-6) Mass
R-BHC Concentration
5.3 (319-85-7) Mass
y-BHC Concentration
5.4 0 El El
(58-89-9) Mass
6-BHC Concentration
5.5 El 0 El
(319-86-8) Mass
Chlordane Concentration
5.6 (57-74-9) Mass
4,4'-DDT Concentration
5.7 (50-29-3) Mass
5.8 4,4'-DDE 0 Concentration
0 0(72-55-9) Mass
5.9 4,4'-DDD Concentration
0 0 0
(72-54-8) Mass
5.10 Dieldrin Concentration
0 0 0
(60-57-1) Mass
5.11 o-endosulfan Concentration
0 0 0
(115-29-7) Mass
EPA Form 3510-2C(Revised 3-19) Page 19

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product 001 OMB No.2040-0004
1=11teE4I011'114ElLIKE1:IU]MtelLICI:1 j[I]LIUZIIbl;le_1:DItio)3[I gel I III Ell 11 ICU YiFklkii(• v
Presence or Absence Intake
(check one) Effluent (optional)
Pollutant/Parameter Testing Units Long Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long- Number
Daily Monthly Term
Present Absent Daily of of
Discharge Discharge Discharge Analyses Average Analyses
(required) (if available) (if available) Value
5.12 R endosulfan 0 0 0 Concentration
(115-29-7) Mass
5.13 Endosulfan sulfate 0 Concentration
(1031-07-8) Mass
Endrin Concentration
5.14 (72-20-8) CI 0 E
Mass
5.15 Endrin aldehyde 0 � Concentration
(7421-93-4) Mass
5.16 Heptachlor 0 0 El Concentration
(76-44-8) Mass
Heptachlor epoxide Concentration
5.17 (1024-57-3) El 0 C Mass
PCB-1242 Concentration
5.18 (53469-21-9) 0 0 C Mass
PCB-1254 Concentration
5.19 (11097-69-1) El 0 0
Mass
PCB-1221 Concentration
5.20 (11104-28-2) 0 0 0Mass
PCB-1232 Concentration
5.21 (11141-16-5) 0 0 0 Mass
PCB-1248 Concentration
5.22 (12672-29-6) El 0 CI
Mass
PCB-1260 Concentration
5.23 (11096-82-5) El 0 Mass
PCB-1016 Concentration
5.24 (12674-11-2) 0 0 0 Mass
EPA Form 3510-2C(Revised 3-19) Page 20

EPA Identification Number NPDES Permit Number Facility Name Outfall Number Form Approved 03/05/19
110043162485 NC0088811 Pharmaceutical Product 001 OMB No.2040-0004
ill110:4r��t4timra'!_ 1111�1r�71r_u••1=kIrsiFsml, •aMITI ODr4ail1th TTif-1,�NM4-ik*Ir�i
Presence or Absence
(check one) Effluent Intake
(optional)
Pollutant/Parameter Testing Units Long-Term
(and CAS Number,if available) Required Believed Believed (specify) Maximum Maximum Average Number Long Term Number
Present Absent
Daily Monthly
aily of of
Discharge Discharge DisDcharge Analyses Average Analyses
(required) (if available) Value
(if available)
Toxaphene Concentration
5.25 (8001-35-2) ❑ ❑ 0 Mass
1 Sampling shall be conducted according to sufficiently sensitive test procedures(i.e.,methods)approved under 40 CFR 136 for the analysis of pollutants or pollutant parameters or
required under 40 CFR chapter I,subchapter N or 0. See instructions and 40 CFR 122.21(e)(3).
EPA Form 3510-2C(Revised 3-19) Page 21

Rain Groundwater
Currently permited
Courtyard Catch Basin Garage Floor Drain Garage Sump Pit Flow Meter Sample Port > to discharge into
CFPUA Sewer Sys.

..„,..,.., i7..!:,,..Z*.:'*.i.rr•;:::. .:,... -1......:.t...,.......:"*..,*Alf,'f)..:$ . *.A.f44%,1". ,,, .1, - . . * . *'4.• . ; .„:;.:.:,.-,,..-...„
ik
. -,,,,,.-:.,:?1,1,,,...:,,i,„„. .,. ....:,,,::.-4,,,.......:,-,-,,,, -..: .. ,, .....4. .: 7:::.:4.4f;N . . 1: Itf.!,.' ,.:, 1. 44,4....••,,,, ... ,,,,
it )7,p4
.61
.. ,...: ,...,,,,,, ,,,.,,.,,, ..: . ,
#. Rom`
,., .. 40..,-...-, .c:rg. (0', •.,•,.... r '''' T',.. :; ',ti X. , .' . ' ' gr..- fit...\,, "f., '' -
--i-4...: i ---,,,,.. .,. - . -.,....... .....:„.. , A ir- ...4;.. . r . .
.,/,,
Fit'''.
,. .. i, , f ,'''' f,....:,' ,Al..''' . '141 ;', 4 k. ., ' 0.'°'°4•64-'.°i''
, . (4k: ' ---''''' ribr:-', :4------",',11114.. IL,..,,-1 . ki . . 4 i 1 e Ai.:.:",;./.. '
- 0'
Ei¢ '
t .$
.,- F., ',-Y! lit it"
1- ''ft : i „:,-.= ,..i• , . $ ,.,. " ' rill!. ar... .1141161111i -:. . /1.0"*"...H..::°' . '' .:. 1..i't.'
' - 1.. 3sC 1 . � tit
•
V —ts'ajba : , r
A.
• „°, ,.-o v im- ° s
1®4
' $ f ..,
7 I 40,01-04'.- :,.--::::-..%,-; 4.:. Ei..! - 4,AL&4.....La . -- . 4 . — . .
''.•. . , — '.: / ' ------ ' .' - ------4;10--' i. -I : , 4,.: Tribii - . :-:..,,,, ..„ ..:. , li
g...4.44 v. vit. ,... ,
. 4 ,,..,,„ .. '- -,,,---
.....A,10.,;„ei....4,; .. . - .:.,,.:... - .,,,..„.. . ...
�i R, , t
t
.,,,..:. ...., ....,, :,, ,, ,, .0.1:).„\
tihiprief, ,,,,f.: . . ,...v.,.,.. . ...0... :::". . ,1..e.s;. . .:::,. ..,..,. .110.... . i - .,,. . .. ,:. ,::
. -u.a ili Mt . . -. .- s ' ' ' N
. it .' ...Via:' .+,..' 4 Ati' ' '..„. .. ..... .,,F.1 a „ 4!.
.,:, ,... -' •,.1,, , 44.--\ „.. .,.,"Vr 114 , N. ,....... -, ..-,, 1-- -,.. - lip _
sick.: lam . ,..... ,. , .1..„. .. ....._ ._ . ..!.,..:, .
' i ' • ' .
- .--,,. Korn (IAR(4.1. A ‘,„„,, 1,, . „.. ,liot
1 a O * ' 'tea -l 'g' 't -RI
f IRS ;it
tr,-, _ I
USGS Quad: K27NW Wilmington, NC
Outfall Facility
Facility
Latitude: 34° 14'35" N 34° 14'45.2" N 4 ��
Location
Longitude:77°57'4"W 77°56'56.3"W
Stream Class: SC, Sw
Subbasin:03 06 23 Pharmaceutical Product Development, Inc.
Receiving Stream: Northeast Cape Fear River North NC0088811 -New Hanover County
L—